NDA/BLA filedoutcome: unknownconf 0.95
kresladi — NDA/BLA filed
$RCKT · ROCKET PHARMACEUTICALS, INC. · Treatment of pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I) due to biallelic variants in ITGB2 without an available human leukocyte antigen-matched sibling donor for allogeneic hematopoietic stem cell transplant
Event date
October 2, 2023
978 days ago
Sponsor runway
10 mo
$144.4M liquid
Evidence
Comparable historical nda/bla fileds· last 5 years · same indication
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $RCKT | kresladi | 2025-10-14 | unknown |
Recent insider activity· ±90 days
6 insiders · 1 buys · 8 sells
Grant
2023-12-07Woods Keith
Director
11,960 @ ——
Grant
2023-12-07Woods Keith
Director
20,522 @ ——
Sell
2023-11-15Makker Gotham
Director
20,000 @ $22.53$451K
Exercise
2023-11-14Militello John
See Remarks
725 @ ——
Exercise
2023-11-14Patel Kinnari
See Remarks
3,989 @ ——
Exercise
2023-11-14Shah Gaurav
CEO
7,979 @ ——
Sell
2023-10-20Militello John
See Remarks
564 @ $17.06$10K
Exercise
2023-10-05Patel Kinnari
See Remarks
3,333 @ ——
Sell
2023-09-29Makker Gotham
Director
4,677 @ $21.14$99K
Sell
2023-09-28Makker Gotham
Director
10,312 @ $21.03$217K
Buy
2023-09-15RTW INVESTMENTS, LP
Director
3,126,955 @ $15.99$50.00M
Other
2023-08-28RTW INVESTMENTS, LP
Director
500,000 @ $22.05$11.03M
Other
2023-08-28RTW INVESTMENTS, LP
Director
1 @ ——
Sell
2023-08-17Patel Kinnari
See Remarks
1,534 @ $15.47$24K
Sell
2023-08-17Militello John
See Remarks
284 @ $15.47$4K
Sell
2023-08-17Shah Gaurav
CEO
4,767 @ $15.47$74K
Exercise
2023-08-14Militello John
See Remarks
725 @ ——
Exercise
2023-08-14Shah Gaurav
CEO
7,979 @ ——
Exercise
2023-08-14Patel Kinnari
See Remarks
3,989 @ ——
Sell
2023-07-20Militello John
See Remarks
573 @ $19.03$11K
Exercise
2023-07-18Militello John
See Remarks
1,586 @ ——